Pharma News, 2025

'Young' immune cells reverse signs of neurodegenerative brain changes in preclinical study by Cedars-Sinai Medical Center

Santhera and Ikris sign distribution agreement for DMD drug in India

With FDA nod, Sanofi's Wayrilz becomes 1st US BTK drug approved for immune thrombocytopenia

Although Saxenda is the first generic GLP-1 to hit the US market, its sales will likely be overshadowed by next-gen drugs such as Wegovy and Zepbound

D3S-001 Receives FDA Breakthrough Therapy, Orphan Drug Designations in Select KRAS G12C-Mutant Solid Tumors

FDA approves mRNA vaccines for new Covid-19 season amid political tension

Lilly links up with JD Health for DTC obesity, diabetes drug sales in China

Rumour partly confirmed as AbbVie acquires Gilgamesh drug

FDA 483 Cites Contamination and Safety Issues at Novo Plant

Rusfertide Receives Breakthrough Therapy Designation for Treatment of Erythrocytosis in Patients with Polycythemia Vera

Daiichi Sankyo and AstraZeneca’s Datroway receives approval in China

Pfizer says it couldn't have warned about tumor risk in Depo-Provera lawsuits